| scholarly article | Q13442814 |
| P50 | author | Manuel Vilanova | Q40685979 |
| Alexandra Correia | Q40686002 | ||
| Laura Oliveira | Q46815248 | ||
| Paulo Correia-de-Sá | Q46815257 | ||
| Fátima Ferreirinha | Q47504323 | ||
| P2093 | author name string | Maria Teresa Magalhães-Cardoso | |
| Ana Cristina Costa | |||
| Sónia Guerra-Gomes | |||
| P2860 | cites work | The changes in the motor end-plate in myasthenia gravis | Q51310113 |
| Naturally occurring CD4+CD25+ regulatory T cells prevent but do not improve experimental myasthenia gravis | Q56899334 | ||
| Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alpha-bungarotoxin-treated rats | Q67482323 | ||
| Adenosine uptake and deamination regulate tonic A2a receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals | Q71474409 | ||
| Presynaptic A1 inhibitory/A2A facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm | Q71951018 | ||
| Role of adenosine deaminase in the early stages of precursor T cell maturation | Q72092665 | ||
| Isozyme analysis of the high serum adenosine deaminase activity in patients with myasthenia gravis | Q72184903 | ||
| Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity | Q84007875 | ||
| ATP released by electrical stimuli elicits calcium transients and gene expression in skeletal muscle. | Q39788355 | ||
| Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides | Q42011931 | ||
| Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve endings of the rat | Q42052807 | ||
| Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis | Q43279093 | ||
| Localization and function of adenosine receptor subtypes at the longitudinal muscle--myenteric plexus of the rat ileum | Q43798111 | ||
| Tetanic failure due to decreased endogenous adenosine A(2A) tonus operating neuronal Ca(v) 1 (L-type) influx in Myasthenia gravis | Q44056136 | ||
| Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis | Q44114291 | ||
| Blockade of neuronal facilitatory nicotinic receptors containing alpha 3 beta 2 subunits contribute to tetanic fade in the rat isolated diaphragm. | Q44436825 | ||
| Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats | Q44757052 | ||
| Sources of adenosine released during neuromuscular transmission in the rat. | Q44838181 | ||
| Adverse effects of myasthenia gravis on rat phrenic diaphragm contractile performance | Q44859084 | ||
| Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase. | Q45938453 | ||
| The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis | Q46434729 | ||
| Myasthenia gravis | Q21202960 | ||
| Neuromuscular junction in health and disease | Q22337158 | ||
| Myasthenia gravis: past, present, and future | Q24678531 | ||
| Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion | Q28507222 | ||
| Ecto-AMP deaminase blunts the ATP-derived adenosine A2A receptor facilitation of acetylcholine release at rat motor nerve endings | Q28570271 | ||
| Tetanic depression is overcome by tonic adenosine A(2A) receptor facilitation of L-type Ca(2+) influx into rat motor nerve terminals | Q28573178 | ||
| Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression | Q29615344 | ||
| A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. | Q30440525 | ||
| Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells | Q33748026 | ||
| Acetylcholine receptors and myasthenia | Q33862589 | ||
| Rat models as tool to develop new immunotherapies | Q34579742 | ||
| Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. | Q34621389 | ||
| Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis | Q35740840 | ||
| Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver. | Q35780855 | ||
| Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID | Q36185196 | ||
| Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. | Q36879416 | ||
| 31P MR spectroscopic assessment of muscle in patients with myasthenia gravis before and after thymectomy: initial experience | Q37083170 | ||
| Histamine induces ATP release from human subcutaneous fibroblasts, via pannexin-1 hemichannels, leading to Ca2+ mobilization and cell proliferation | Q37189598 | ||
| Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model | Q38093706 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | myasthenia gravis | Q8285 |
| P304 | page(s) | 460610 | |
| P577 | publication date | 2015-01-27 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Deficits in endogenous adenosine formation by ecto-5'-nucleotidase/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis | |
| P478 | volume | 2015 |
| Q59256385 | Metabolic control of T cell immune response through glycans in inflammatory bowel disease |
| Q90192554 | Opposing Effects of Adenosine and Inosine in Human Subcutaneous Fibroblasts May Be Regulated by Third Party ADA Cell Providers |
| Q42367885 | Purinergic Signalling: Therapeutic Developments |
| Q47647759 | Purines and Carotid Body: New Roles in Pathological Conditions. |
| Q38416292 | Repeated Electroacupuncture Persistently Elevates Adenosine and Ameliorates Collagen-Induced Arthritis in Rats |
| Q39261822 | Synaptic Homeostasis and Its Immunological Disturbance in Neuromuscular Junction Disorders |
| Q92999338 | The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases |
| Q28069199 | The role of adenosinergic pathway in human autoimmune diseases |
Search more.